OSUR OraSure Technologies, Inc.

NASDAQ
$3.97

OraSure Technologies, Inc. (OSUR) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is a loss of $0.22 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.5% since its last earnings release on August 5, 2026.

OraSure Technologies Reported Earnings
Wednesday, August 5, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.22)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About OraSure Technologies, Inc.

OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.

Sector

Healthcare

Industry

Diagnostic Substances

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.